CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 50 enrolled
Drug / intervention
Radiesse® Injectable Dermal Filler Mixed with Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01012661
NCT01012661Phase 4Completed
CompareCT.gov

Evaluation of Pain With the Use of Lidocaine-Mixed Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds

Merz North America, Inc.·interventional·Posted Nov 13, 2009·Updated Apr 26, 2013

In Brief

A Phase 4 clinical trial evaluating Radiesse® Injectable Dermal Filler Mixed with Lidocaine and Radiesse® Injectable Dermal Filler without Lidocaine for Nasolabial Folds. Completed, enrolled 50 participants across 2 sites.

Detailed Summary

To assess pain during nasolabial fold treatment using Radiesse® Injectable Dermal Filler mixed with lidocaine.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasolabial Folds
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 13, 2009
Enrollment StartSep 1, 2008
Primary CompletionDec 1, 2008
Study CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 16.6 years ago

Interventions

Radiesse® Injectable Dermal Filler Mixed with Lidocainedevice

Calcium hydroxylapatite particles suspended in an aqueous based gel carrier mixed with 2% lidocaine hydrochloride (HCl)

Radiesse® Injectable Dermal Filler without Lidocainedevice

Calcium hydroxylapatite particles suspended in an aqueous based gel carrier without 2% lidocaine hydrochloride (HCl)